Communicable disease threats report, 8-14 July 2018, week 28
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 July 2018 and includes updates on carbapenemase-producing (OXA-48) Klebsiella pneumoniae, dengue, Ebola virus disease, poliomyelitis, MERS-CoV, mass gathering monitoring (FIFA Men's Football World Cup), measles, poliovirus type 2, rubella, Vibrio growth in the Baltic Sea, and West Nile virus.
Rise of carbapenem-resistant Enterobactericaeae: A threat to health in Europe
Infections with bacteria resistant to carbapenems, a group of highly effective antibiotics, pose a significant threat to patients and healthcare systems in all EU/EEA countries, warns ECDC in a Rapid Risk Assessment.
Communicable Disease Threats Report, 3-9 June 2018, week 23
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 June 2018 and includes updates on dengue, Vibrio growth in the Baltic Sea, measles, rubella, hepatitis A, mass gathering monitoring, Carbapenem-resistant Enterobacteriaceae, Ebola virus disease, West Nile virus, polio and MERS-CoV.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae - first update
This update of the 2016 ECDC Rapid Risk Assessment on carbapenem-resistant Enterobacteriaceae (CRE) evaluates the risk for patients and healthcare systems in EU/EEA countries due to the global spread of CRE.
ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.
Call for scientific collaboration to support genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU-level
ECDC is looking to establish a scientific collaboration with an organisation which can perform whole genome sequencing (WGS), carry out related data analyses, and visualise the results.
Rapid Risk Assessment: Plasmid-mediated colistin resistance in Enterobacteriaceae, 15 June 2016
This document assesses the risk for patients and healthcare systems in the EU/EEA due to the global mcr-1 plasmid-mediated gene epidemic.
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae, 14 April 2016
This rapid risk assessment provides several options to reduce the risk of CRE, e.g. treatment options, transmission prevention and measures related to the healthcare system.
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015
Albiger, B., Glasner, C., Struelens, M.J., Grundmann, H., Monnet, D.L.
Carbapenemase-producing bacteria in Europe
This report summarises the results of a survey to gather information about the spread of carbapenemase-producing Enterobacteriaceae and carbapenems-resistant Acinetobacter baumannii in Europe.